Literature DB >> 18781630

Increasing process understanding by analyzing complex interactions in experimental data.

Kaisa Naelapää1, Morten Allesø, Henning G Kristensen, Rasmus Bro, Jukka Rantanen, Poul Bertelsen.   

Abstract

There is a recognized need for new approaches to understand unit operations with pharmaceutical relevance. A method for analyzing complex interactions in experimental data is introduced. Higher-order interactions do exist between process parameters, which complicate the interpretation of experimental results. In this study, experiments based on mixed factorial design of coating process were performed. Drug release was analyzed by traditional analysis of variance (ANOVA) and generalized multiplicative ANOVA (GEMANOVA). GEMANOVA modeling is introduced in this study as a new tool for increased understanding of a coating process. It was possible to model the response, that is, the amount of drug released, using both mentioned techniques. However, the ANOVA model was difficult to interpret as several interactions between process parameters existed. In contrast to ANOVA, GEMANOVA is especially suited for modeling complex interactions and making easily understandable models of these. GEMANOVA modeling allowed a simple visualization of the entire experimental space. Furthermore, information was obtained on how relative changes in the settings of process parameters influence the film quality and thereby drug release.

Mesh:

Substances:

Year:  2009        PMID: 18781630     DOI: 10.1002/jps.21565

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Quality-by-design case study: investigation of the role of poloxamer in immediate-release tablets by experimental design and multivariate data analysis.

Authors:  Goldi Kaul; Jun Huang; Ramarao Chatlapalli; Krishnendu Ghosh; Arwinder Nagi
Journal:  AAPS PharmSciTech       Date:  2011-08-23       Impact factor: 3.246

Review 2.  The Future of Pharmaceutical Manufacturing Sciences.

Authors:  Jukka Rantanen; Johannes Khinast
Journal:  J Pharm Sci       Date:  2015-08-17       Impact factor: 3.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.